Skip to main content
. 2011 Dec;22(Suppl 8):viii5–viii15. doi: 10.1093/annonc/mdr516

Figure 2.

Figure 2.

Synthetic lethality produced by inhibiting the PI3K and MEK signaling pathways. Inhibition of PI3K or MEK signaling individually fails to exert toxicity, whereas inhibiting both pathways kills cancer cells (courtesy of Dr David Gershenson). RTK, receptor tyrosine kinase.